Stephen Shuttleworth

Stephen Shuttleworth has a long and varied work experience. Stephen began their career in 1997 as a Research Leader in Chemistry at Biochem Pharma Inc. In 2000, they moved to Tularik Inc. as an Associate Director of Chemistry. In 2003, they joined Piramed Ltd. as the Director of Chemistry. From 2006 to 2014, they worked at Cancer Research UK as the Head of New Projects Development. In 2008, they began their tenure at Karus Therapeutics Limited, where they have held multiple roles, including Chair of the Scientific Advisory Board, CSO and Executive Director, and COO and Executive Director. In 2014, they became an Honorary Professor of Molecular & Clinical Cancer Sciences at The University of Manchester. In 2019, they took on multiple roles, including Venture Partner at Samsara BioCapital, CTO at Nalo Therapeutics, Inc., Scientific Advisor at Autobahn Labs, Inc., and Non Executive Director at HOX Therapeutics Limited.

Stephen Shuttleworth began their education in 1981 at St Edward's College, Liverpool. Stephen then attended the University of Liverpool from 1988 to 1991, where they obtained their BSc (Hons) in Chemistry. Stephen continued their studies at the University of Liverpool, earning their PhD in Organic Chemistry in 1994. In 2007, they obtained the Fellow of the Royal Society of Chemistry and Chartered Chemist certification from the Royal Society of Chemistry.